Atlas Trials

Stromal Vascular Fraction and Autologous Activated Platelet-Rich Plasma Combination in Treating Treatment of Type 2 Diabetes

Clinical trial NCT05925829 · COMPLETED

Trial details

NCT number
NCT05925829
Sponsor
Hayandra Peduli Foundation
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 2Platelet-rich PlasmaStromal Vascular Fraction
Start date
2017-01-01
Primary completion
2017-12-01
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.